Further exploration is warranted to assess the broader impact of TRIM28 on the NF-κB-dependent expression of cytokines and chemokines within the immunosuppressive tumor microenvironment of NSCLC. This evidence concerns the gene NFKB1 and non-small cell lung carcinoma.